Literature DB >> 7904048

Effect of acute and repeated administration of 5-HT1A receptor agonists on 5-HT release in rat brain in vivo.

T Sharp1, R McQuade, S Bramwell, S Hjorth.   

Abstract

1. Electrophysiological measurements of 5-HT neuronal activity report that repeated administration of 5-HT1A receptor agonists leads to desensitization of the 5-HT1A autoreceptor but this has not yet been detected in measurements of brain 5-HT synthesis or metabolism. Here we have determined the effect of repeated administration of 5-HT1A receptor agonists on brain 5-HT release using microdialysis. 2. Acute administration of the 5-HT1A receptor agonists buspirone (0.1-5 mg/kg s.c.) and ipsapirone (0.03-3 mg/kg s.c.) caused a dose-dependent decrease in 5-HT output in ventral hippocampus of the chloral hydrate anaesthetized rat. 3. The 5-HT response to buspirone (0.1 and 0.5 mg/kg s.c.) and ipsapirone (0.3 mg/kg s.c.) was significantly inhibited by pre-treatment with the 5-HT1/beta-adrenoceptor antagonist pindolol (8-16 mg/kg s.c.). The 5-HT response to buspirone (0.1 mg/kg s.c.) and ipsapirone (0.3 mg/kg s.c.) was not blocked by pretreatment with a combination of the beta 1 and beta 2-adrenoceptor antagonists metoprolol and ICI 118,551 (4 mg/kg s.c.). 4. The effect of an acute challenge of buspirone (0.5 mg/kg s.c.) on 5-HT output in ventral hippocampus was not attenuated in rats treated twice daily for 14 days with 0.5 or 5 mg/kg s.c. buspirone compared to saline-injected controls. Similarly, the decrease in 5-HT induced by an acute challenge of ipsapirone (0.5 mg/kg s.c.) was not attenuated in rats treated twice daily for 14 days with 5 mg/kg s.c. ipsapirone.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7904048     DOI: 10.1007/bf00171331

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  37 in total

1.  Autoradiography of serotonin receptor subtypes in the central nervous system.

Authors:  F Radja; A M Laporte; G Daval; D Vergé; H Gozlan; M Hamon
Journal:  Neurochem Int       Date:  1991       Impact factor: 3.921

2.  Behavioral effects of acute and chronic buspirone.

Authors:  J G Wettstein
Journal:  Eur J Pharmacol       Date:  1988-07-07       Impact factor: 4.432

3.  Serotonergic mechanisms in the behavioral effects of buspirone and gepirone.

Authors:  A S Eison; M S Eison; M Stanley; L A Riblet
Journal:  Pharmacol Biochem Behav       Date:  1986-03       Impact factor: 3.533

Review 4.  Serotonin-specific drugs for anxiety and depressive disorders.

Authors:  D S Charney; J H Krystal; P L Delgado; G R Heninger
Journal:  Annu Rev Med       Date:  1990       Impact factor: 13.739

5.  The long-term effects of 8-hydroxy-2-(di-n-propyl-amino)tetralin (8-OH-DPAT) on copulatory and exploratory behaviour in male rats.

Authors:  C E Johansson; B J Meyerson; A U Höglund
Journal:  Eur J Pharmacol       Date:  1990-03-13       Impact factor: 4.432

6.  Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.

Authors:  L E Schechter; F J Bolaños; H Gozlan; L Lanfumey; S Haj-Dahmane; A M Laporte; C M Fattaccini; M Hamon
Journal:  J Pharmacol Exp Ther       Date:  1990-12       Impact factor: 4.030

7.  The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat.

Authors:  M D Tricklebank; C Forler; J R Fozard
Journal:  Eur J Pharmacol       Date:  1984-11-13       Impact factor: 4.432

8.  Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists.

Authors:  J S Sprouse; G K Aghajanian
Journal:  Synapse       Date:  1987       Impact factor: 2.562

9.  Activation of the 5-HT1A receptor subtype increases rat plasma ACTH concentration.

Authors:  F Gilbert; C Brazell; M D Tricklebank; S M Stahl
Journal:  Eur J Pharmacol       Date:  1988-03-15       Impact factor: 4.432

10.  Inhibition of serotonergic dorsal raphe neurons by systemic and iontophoretic administration of buspirone, a non-benzodiazepine anxiolytic drug.

Authors:  C P VanderMaelen; G K Matheson; R C Wilderman; L A Patterson
Journal:  Eur J Pharmacol       Date:  1986-09-23       Impact factor: 4.432

View more
  14 in total

1.  Ex vivo inhibitory effect of the 5-HT uptake blocker citalopram on 5-HT synthesis.

Authors:  C Moret; M Briley
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

Review 2.  Effects of citalopram on serotonin and CRF systems in the midbrain of primates with differences in stress sensitivity.

Authors:  Cynthia L Bethea; Fernanda B Lima; Maria L Centeno; Karin V Weissheimer; Olga Senashova; Arubala P Reddy; Judy L Cameron
Journal:  J Chem Neuroanat       Date:  2011-06-06       Impact factor: 3.052

3.  Rapid desensitization of somatodendritic 5-HT1A receptors by chronic administration of the high-efficacy 5-HT1A agonist, F13714: a microdialysis study in the rat.

Authors:  M-B Assié; H Lomenech; V Ravailhe; V Faucillon; A Newman-Tancredi
Journal:  Br J Pharmacol       Date:  2006-08-14       Impact factor: 8.739

4.  Role of 5-HT(1A) receptors in the modulation of stress-induced lactate metabolism in the medial prefrontal cortex and basolateral amygdala.

Authors:  Takashi Uehara; Tomiki Sumiyoshi; Tadasu Matsuoka; Hiroko Itoh; Masayoshi Kurachi
Journal:  Psychopharmacology (Berl)       Date:  2006-04-05       Impact factor: 4.530

5.  EEG effects of buspirone and pindolol: a method of examining 5-HT1A receptor function in humans.

Authors:  R H McAllister-Williams; A E Massey
Journal:  Psychopharmacology (Berl)       Date:  2003-02-13       Impact factor: 4.530

6.  Drug-induced defaecation in rats: role of central 5-HT1A receptors.

Authors:  T Croci; M Landi; A Bianchetti; L Manara
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

7.  Effects of acute and chronic buspirone on impulsive choice and efflux of 5-HT and dopamine in hippocampus, nucleus accumbens and prefrontal cortex.

Authors:  Y P Liu; L S Wilkinson; T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2004-01-15       Impact factor: 4.530

8.  Efficacy of buspirone for attenuating cocaine and methamphetamine reinstatement in rats.

Authors:  Keith L Shelton; Elizabeth S Hendrick; Patrick M Beardsley
Journal:  Drug Alcohol Depend       Date:  2013-01-29       Impact factor: 4.492

9.  Increase of noradrenaline release in the hypothalamus of freely moving rat by postsynaptic 5-hydroxytryptamine1A receptor activation.

Authors:  M Suzuki; T Matsuda; S Asano; P Somboonthum; K Takuma; A Baba
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

Review 10.  5-HT1A receptor agonists: recent developments and controversial issues.

Authors:  J De Vry
Journal:  Psychopharmacology (Berl)       Date:  1995-09       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.